QUIDELORTHO CORP Increase (Decrease) in Employee Related Liabilities
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Employee Related Liabilities of -$45.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for the quarter ending 2026-06-28 was -$60.70M.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for the quarter ending 2026-03-29 was $15.70M, a 7.65% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for the quarter ending 2025-12-28 was $15.80M, a 116.44% increase year-over-year.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for the quarter ending 2025-09-28 was $20.00M, a 20.32% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for fiscal 2025 was $900.00K, a 97.43% decline from fiscal 2024.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for fiscal 2024 was $35.00M.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for fiscal 2023 was -$53.90M, a 396.15% decline from fiscal 2023.
- QUIDELORTHO CORP increase (decrease) in employee related liabilities for fiscal 2023 was $18.20M, a 264.00% increase from fiscal 2022.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$60.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$45.00M 10-Q · filed 2026-08-07 | -$29.20M derived: sum of 3 quarters · filed 2026-08-07 | -$9.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $15.70M 10-Q · filed 2026-05-06 | $31.50M derived: sum of 2 quarters · filed 2026-05-06 | $51.50M derived: sum of 3 quarters · filed 2026-05-06 | -$400.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $15.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $35.80M derived: sum of 2 quarters · filed 2026-02-19 | -$16.10M derived: sum of 3 quarters · filed 2026-08-07 | $900.00K 10-K · filed 2026-02-19 |
| 2025-09-28 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$31.90M derived: sum of 2 quarters · filed 2026-08-07 | -$14.90M 10-Q · filed 2025-11-06 | -$7.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$51.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$34.90M 10-Q · filed 2026-08-07 | -$27.60M derived: sum of 3 quarters · filed 2026-08-07 | -$2.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $17.00M 10-Q · filed 2026-05-06 | $24.30M derived: sum of 2 quarters · filed 2026-05-06 | $49.40M derived: sum of 3 quarters · filed 2026-05-06 | $26.30M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $32.40M derived: sum of 2 quarters · filed 2026-02-19 | $9.30M derived: sum of 3 quarters · filed 2026-02-19 | $35.00M 10-K · filed 2026-02-19 |
| 2024-09-29 | $25.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.00M derived: sum of 2 quarters · filed 2025-11-06 | $27.70M 10-Q · filed 2025-11-06 | $4.80M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.60M 10-Q · filed 2025-08-06 | -$20.30M derived: sum of 3 quarters · filed 2026-02-19 | $5.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $25.70M 10-Q · filed 2025-05-08 | $2.80M derived: sum of 2 quarters · filed 2026-02-19 | $28.80M derived: sum of 3 quarters · filed 2026-02-19 | $1.40M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$22.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.10M derived: sum of 2 quarters · filed 2026-02-19 | -$24.30M derived: sum of 3 quarters · filed 2026-02-19 | -$53.90M 10-K · filed 2026-02-19 |
| 2023-10-01 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.40M derived: sum of 2 quarters · filed 2024-11-08 | -$31.00M 10-Q · filed 2024-11-08 | -$9.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$27.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$57.00M 10-Q · filed 2024-08-01 | -$35.20M derived: sum of 3 quarters · filed 2025-02-27 | -$29.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$29.60M 10-Q · filed 2024-05-09 | -$7.80M derived: sum of 2 quarters · filed 2025-02-27 | -$2.30M derived: sum of 3 quarters · filed 2025-02-27 | -$500.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $21.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $27.30M derived: sum of 2 quarters · filed 2025-02-27 | $29.10M derived: sum of 3 quarters · filed 2025-02-27 | $18.20M 10-K · filed 2025-02-27 |
| 2022-10-02 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.30M derived: sum of 2 quarters · filed 2023-11-02 | -$3.60M 10-Q · filed 2023-11-02 | $5.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$9.10M 10-Q · filed 2023-08-09 | -$200.00K derived: sum of 3 quarters · filed 2024-08-01 | $12.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | -$10.90M 10-Q · filed 2023-05-04 | -$2.00M derived: sum of 2 quarters · filed 2024-08-01 | $10.20M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $8.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $21.10M derived: sum of 2 quarters · filed 2024-08-01 | $5.00M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$3.90M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | -$16.10M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $16.00M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |